Invention Application
- Patent Title: CORONAVIRUS VACCINE
-
Application No.: US18526938Application Date: 2023-12-01
-
Publication No.: US20240366751A1Publication Date: 2024-11-07
- Inventor: Alexander Muik , Asaf Poran , Kena Anne Swanson , Qi Yang , Hui Cai , Ugur Sahin , Kayvon Modjarrad
- Applicant: BioNTech SE
- Applicant Address: DE Mainz
- Assignee: BioNTech SE
- Current Assignee: BioNTech SE
- Current Assignee Address: DE Mainz
- Priority: WOPCT/EP2022/083740 20221129
- Main IPC: A61K39/215
- IPC: A61K39/215 ; A61K39/00 ; C07K14/005
Abstract:
This disclosure relates to the field of RNA to prevent or treat coronavirus infection. In particular, the present disclosure relates to methods and agents for vaccination against coronavirus infection and inducing effective coronavirus antigen-specific immune responses such as antibody and/or T cell responses.
Public/Granted literature
- US2172318A Marking device Public/Granted day:1939-09-05
Information query
